Anti-Therapeutic Action: loss of consciousness

Postpartum depression: A role for psychedelics?

Postpartum depression affects many new mothers and involves feelings of disconnection from themselves and their babies. This review suggests that psilocybin, the active compound in psychedelic mushrooms, might help by promoting reconnection and acceptance. The authors examine safety data suggesting psilocybin could potentially be used safely in postpartum women if appropriate precautions are taken, such as temporarily stopping breastfeeding after treatment.

Read More »

Online Availability of Diamond Shruumz Before and After FDA Recall Initiation: Qualitative Assessment and Simulated Test Purchasing

Diamond Shruumz mushroom-based edible products caused severe illnesses in consumers and were recalled by the FDA in June 2024. Researchers discovered that despite the recall, many online sellers continued to advertise and sell these products across social media and websites. The study found that even two weeks after the recall, about one-third of the websites still successfully completed product sales, showing how difficult it is for regulators to enforce recalls on the internet.

Read More »
Scroll to Top